Dr. Stephen Hiscox: non-receptor tyrosine kinases as therapeutic targets in metastasis

Dr. Stephen Hiscox (Figure 1) is currently Senior Lecturer in Cancer Biology within the School of Pharmacy and Pharmaceutical Sciences, Cardiff University, UK. He has a longstanding interest in cancer invasion and metastasis particularly in the context of drug resistance in a broad range of tumor types. His early translational work at the School of Medicine in Cardiff focused on understanding the role of c-Met signaling in GI cancers and his subsequent lab in the School of Pharmacy was one of the first to identify a role for Src family kinases in the acquired drug resistant phenotype in breast cancer.